Bicara Therapeutics (BCAX) Amortizatization of Intangibles (2024 - 2026)
Bicara Therapeutics (BCAX) posted quarterly Amortizatization of Intangibles of -$338000.0 for Q1 2026, down 25.65% quarter-over-quarter from -$269000.0 in Q4 2025.
Powered by 
Analysis
Bicara Therapeutics (BCAX) Amortizatization of Intangibles (2024 - 2026) Analysis & Trends
Bicara Therapeutics' Amortizatization of Intangibles history runs 2 years deep, the most recent figure standing at -$338000.0 for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles changed N/A year-over-year to -$338000.0; the TTM figure through Mar 2026 stood at -$607000.0 (changed N/A YoY), while the FY2025 annual figure was -$301000.0, changed N/A from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at -$338000.0, down from -$269000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was -$269000.0 in Q4 2025, with the low at -$338000.0 in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 4.33 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 678,000.00 |
| 10 | Bicara Therapeutics | 1.57 Bn | 1.57 Bn | - | -237,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -237,000.00 |
| Mar 31, 2026 | -338,000.00 |
| Dec 31, 2025 | -899,000.00 |
| Sep 30, 2025 | 249,000.00 |
| Jun 30, 2025 | 211,000.00 |
| Mar 31, 2025 | 138,000.00 |
| Dec 31, 2024 | -199,000.00 |
| Sep 30, 2024 | 68,000.00 |
| Jun 30, 2024 | 66,000.00 |
| Mar 31, 2024 | 65,000.00 |